![Anne-Laure Autret-Cornet](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anne-Laure Autret-Cornet
Directeur Administratif chez
OSE IMMUNOTHERAPEUTICS
Profil
Anne-Laure Autret-Cornet currently works at OSE Immunotherapeutics SA, as Director & Chief Administrative Officer from 2025.
Ms. Autret-Cornet also formerly worked at Deloitte SAS, as Auditor and Effimune SA, as Manager-Financial & Administrative from 2013 to 2016.
Ms. Autret-Cornet received her undergraduate degree from Ecole Supérieure De Commerce D'angers.
Postes actifs de Anne-Laure Autret-Cornet
| Sociétés | Poste | Début |
|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur Administratif | 01/05/2016 |
Anciens postes connus de Anne-Laure Autret-Cornet
| Sociétés | Poste | Fin |
|---|---|---|
Effimune SA
 Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Directeur Financier/CFO | 01/01/2016 |
Deloitte SAS
 Deloitte SAS Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, consulting, financial advisory and legal services | Corporate Officer/Principal | - |
Formation de Anne-Laure Autret-Cornet
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Deloitte SAS
Deloitte SAS Miscellaneous Commercial ServicesCommercial Services Provides accounting, tax, consulting, financial advisory and legal services | Commercial Services |
Ecole Supérieure De Commerce D'angers
 Ecole Supérieure De Commerce D'angers Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Effimune SA
Effimune SA BiotechnologyHealth Technology Engages in the research and development of drugs for transplantation and immune-mediated diseases | Health Technology |
OSE Immunotherapeutics SA
 OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers | Health Technology |
